NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/01/2024
Back to search
Official data from USPTO
A+O=D2 CONTROL YOUR VARIABLES DRUG DIVERSION VISANTE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
57
Latest update
11/01/2024
Trademark type
Combined
Nice classes
35
Filing date
11/18/2016
Registration date
06/05/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/01/2024
Last transaction
11/01/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/07/2017
First use in commerce
10/07/2017
Drawing code
3
Owner type
16
Owner location
ST. PAUL, MN, US
Examiner
FERRAIUOLO, DOMINIC
Current location
Historical data usage
Mark description
The mark consists of "A+O=D2" in block letters with the "2" being in superscript, the phrases "CONTROL YOUR VARIABLES" and "DRUG DIVERSION" are underneath and the stylized wording "VISANTE" is at the bottom, all over a shaded rectangular background.
Holders and representatives
Holders
VISANTE CONSULTING LLC
Visante, Inc.
Representatives
Ashley G. Kessler Cozen O'Connor
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business management services for pharmacy automation systems of othershelp pharmaceutical manufacturers and technology firms to expand their market reach while improving patient care through the optimal use of their products and services; Business consultation services related to the pharmacy field regarding clinicaloperational and financial metrics relating to potential drug diversionsclinical assessmentwork load efficiencyequipment utilizationinventory optimizationcost trackingprescription refillingdiscrepancystock out and waste analysis
Publications
History of USPTO decisions and trademark events.
57 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/01/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/01/2024
E815
TEAS SECTION 8 & 15 RECEIVED
05/13/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/01/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/05/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/16/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
11/16/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/16/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/16/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/14/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/16/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/16/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/16/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/16/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/16/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/03/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/03/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
06/05/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/20/2018
PUBO
PUBLISHED FOR OPPOSITION
03/20/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/28/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/15/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
02/15/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/15/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
02/15/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/15/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/25/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/25/2018
ALIE
ASSIGNED TO LIE
01/23/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/09/2018
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
10/13/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/12/2017
GNRT
NON-FINAL ACTION E-MAILED
10/12/2017
CNRT
NON-FINAL ACTION WRITTEN
10/12/2017
IUAA
USE AMENDMENT ACCEPTED
10/12/2017
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
10/10/2017
IUAF
USE AMENDMENT FILED
10/10/2017
EAAU
TEAS AMENDMENT OF USE RECEIVED
10/09/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/18/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/18/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/18/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/13/2017
GNRT
NON-FINAL ACTION E-MAILED
09/13/2017
CNRT
NON-FINAL ACTION WRITTEN
09/13/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/22/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/21/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/21/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/07/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/07/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/07/2017
GNRT
NON-FINAL ACTION E-MAILED
03/07/2017
CNRT
NON-FINAL ACTION WRITTEN
03/07/2017
DOCK
ASSIGNED TO EXAMINER
02/25/2017
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/26/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/25/2016
NWAP
NEW APPLICATION ENTERED
11/22/2016
Continuous trademark protection
Get notified about every new filing that threatens A+O=D2 CONTROL YOUR VARIABLES DRUG DIVERSION VISANTE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.